An estimated 31 million Americans live with chronic kidney disease (CKD). Treatment involves controlling symptoms, reducing complications, and slowing progression of the disease. Some people with CKD also become anemic. Symptoms of anemia include weakness, fatigue, and chest pain. Cardiovascular disease is also common in people with CKD.
Clinical trials test whether a new potential treatment is safe and effective for patients. There are many reasons people choose to join clinical trials, including access to treatment, receiving quality care, and helping research. The decision to join a clinical trial is always a choice, and you can leave a clinical trial at any time, for any reason.